000 | 01982 a2200553 4500 | ||
---|---|---|---|
005 | 20250514050933.0 | ||
264 | 0 | _c20030618 | |
008 | 200306s 0 0 eng d | ||
022 | _a0888-8809 | ||
024 | 7 |
_a10.1210/me.2002-0036 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRieusset, Jennifer | |
245 | 0 | 0 |
_aA new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. _h[electronic resource] |
260 |
_bMolecular endocrinology (Baltimore, Md.) _cNov 2002 |
||
300 |
_a2628-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _a3T3 Cells |
650 | 0 | 4 |
_aAdipocytes _xcytology |
650 | 0 | 4 |
_aAdipose Tissue _xdrug effects |
650 | 0 | 4 |
_aAdipose Tissue, Brown _xdrug effects |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Obesity Agents _xpharmacology |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aEpididymis |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aInsulin _xpharmacology |
650 | 0 | 4 |
_aInsulin Resistance _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aOrganophosphorus Compounds _xpharmacology |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xantagonists & inhibitors |
650 | 0 | 4 | _aRosiglitazone |
650 | 0 | 4 |
_aThiazoles _xpharmacology |
650 | 0 | 4 | _aThiazolidinediones |
650 | 0 | 4 |
_aTranscription Factors _xantagonists & inhibitors |
700 | 1 | _aTouri, Fethi | |
700 | 1 | _aMichalik, Liliane | |
700 | 1 | _aEscher, Pascal | |
700 | 1 | _aDesvergne, Béatrice | |
700 | 1 | _aNiesor, Eric | |
700 | 1 | _aWahli, Walter | |
773 | 0 |
_tMolecular endocrinology (Baltimore, Md.) _gvol. 16 _gno. 11 _gp. 2628-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/me.2002-0036 _zAvailable from publisher's website |
999 |
_c12212259 _d12212259 |